CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,483 | -37.0% | 14,558 | 0.0% | 0.00% | – |
| Q2 2023 | $53,137 | -11.4% | 14,558 | +18.8% | 0.00% | – |
| Q1 2022 | $60,000 | -56.8% | 12,253 | 0.0% | 0.00% | – |
| Q4 2021 | $139,000 | -22.8% | 12,253 | -0.6% | 0.00% | – |
| Q3 2021 | $180,000 | +25.0% | 12,325 | 0.0% | 0.00% | – |
| Q2 2021 | $144,000 | -11.1% | 12,325 | -7.0% | 0.00% | – |
| Q1 2021 | $162,000 | -43.8% | 13,249 | -42.4% | 0.00% | -100.0% |
| Q4 2020 | $288,000 | -2.0% | 23,019 | +17.8% | 0.00% | 0.0% |
| Q3 2020 | $294,000 | +23.0% | 19,540 | +100.0% | 0.00% | 0.0% |
| Q2 2020 | $239,000 | +60.4% | 9,770 | -7.1% | 0.00% | – |
| Q1 2020 | $149,000 | -10.8% | 10,514 | 0.0% | 0.00% | – |
| Q4 2019 | $167,000 | – | 10,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |